Monitoring of efficacy, tolerability and safety of artemether–lumefantrine and artesunate–amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Lambaréné, Gabon: an open-label clinical trial

BACKGROUND: Malaria remains a major public health problem, affecting mainly low-and middle-income countries. The management of this parasitic disease is challenged by ever increasing drug resistance. This study, investigated the therapeutic efficacy, tolerability and safety of artemether–lumefantrin...

Descripción completa

Detalles Bibliográficos
Autores principales: Adegbite, Bayode R., Edoa, Jean R., Honkpehedji, Yabo J., Zinsou, Frejus J., Dejon-Agobe, Jean C., Mbong-Ngwese, Mirabeau, Lotola-Mougueni, Fabrice, Koehne, Erik, Lalremruata, Albert, Kreidenweiss, Andrea, Nguyen, The T., Kun, Jutta, Agnandji, Selidji T., Lell, Bertrand, Safiou, Abdou R., Obone Atome, Fridia A., Mombo-Ngoma, Ghyslain, Ramharter, Michael, Velavan, Thirumalaisamy P., Mordmüller, Benjamin, Kremsner, Peter G., Adegnika, Ayola A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6916217/
https://www.ncbi.nlm.nih.gov/pubmed/31842893
http://dx.doi.org/10.1186/s12936-019-3015-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6916217/
https://www.ncbi.nlm.nih.gov/pubmed/31842893
http://dx.doi.org/10.1186/s12936-019-3015-4

Ejemplares similares